Nene Remote Monitoring Proof of Concept

Stroke Clinical Trial

Official title:

NHS England Proof of Concept - Smart Tech - Nene CCG

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04598659
• Other study ID #: NPoC1
• Status: Completed
• Start date: January 6, 2021
• Est. completion date: March 6, 2022

Study information

• Verified date: January 2024
• Source: Doccla UK
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This feasibility study is being conducted to investigate the practicalities and potential benefits of equipping patients with wearable monitoring devices.

Description:

Vital signs are important indicators used in healthcare to inform a patient's treatment options and care plan. However, the opportunity to monitor vital signs is largely limited to the time a patient spends at a healthcare providers premises. This study is being conducted to see if the use of small wearable monitoring devices could help deliver a better service and improve patient care by continuing to monitor patients remotely. The study is observational and has been designed to address two key questions: 1. Is it possible in principle to use the information captured from the devices to improve the treatment of the patient? 2. How practical is it to implement remote patient monitoring (RPM)? To address these questions, consenting patients will be asked to wear a small adhesive biosensor for a short period of time following discharge from hospital (either as an outpatient or inpatient). The data gathered by the device will be examined retrospectively and patients will not be monitored in real-time. Following the monitoring period, the vital signs data captured by the device will be analysed to see if it correlates with any unscheduled healthcare needs (such as unplanned GP appointments or emergency hospital visits). Specifically, the study team will be investigating whether the monitoring could have picked up a nascent problem before it became more serious, or whether monitoring could have saved the patient from having to make a trip to see their GP. Information regarding the practicalities of implementing RPM will be captured by monitoring compliance and through an exit interview with participating patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 180
• Est. completion date: March 6, 2022
• Est. primary completion date: January 6, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The participant is able to provide informed consent.
• The participant is able to comply with the English instructions for using a wearable device (e.g, follow simple instructions, able to answer the telephone, able to answer symptom questions, etc.).
• The participant may have been recently discharged from a hospital care setting (including emergency departments, ward and acute assessment units) to home (including a relative's home) or be currently admitted to a hospital care setting.
• The participant has a recent medical history that suggests there is a risk their health may deteriorate at home. In the first instance we will focus upon patients with

at least one of the following conditions:

• Heart Failure (the patient being discharged),
• Arrhythmia (e.g. patient on the waitlist for a pacemaker)
• We will also consider patients with other conditions that present a risk of deterioration at home, for example: COPD, stable angina, liver failure, minor trauma, chronic kidney disease, stroke, hypertension, cancer ( e.g. recent surgery)

Exclusion Criteria:

• Patients that are clinically unstable (eg: respiratory distress, ongoing angina pectoris, sepsis, etc).
• Aphasia or other conditions that prevents the patient from adequately communicating with the researchers.
• Terminal diagnosis with life expectancy < 3 months.
• Ongoing renal dialysis, or other treatment that prevents the patient from being at home for extended periods.
• Dementia or uncontrolled psychiatric illness.
• Severe dermatitis or another skin disorder that prevents the patient from wearing a patch.
• Patient has a pacemaker or ICD
• Other inability, or unwillingness, to adequately co-operate with the RPM-team.

Related Conditions & MeSH terms

• Cardiovascular Diseases
• Heart Failure
• Respiration Disorders
• Respiratory Disease
• Respiratory Tract Diseases
• Stroke

Locations

Country	Name	City	State
United Kingdom	Northampton General Hospital	Northampton

Sponsors (3)

Lead Sponsor	Collaborator
Doccla UK	NHS Nene Clinical Commissioning Group, Northampton General Hospital NHS Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient compliance	The percentage of all participating patients for whom a complete and unbroken record of their vital signs is obtained throughout the duration of the agreed monitoring period.	7 days (the monitoring period)
Secondary	Device comfort assessed by a 5-point rating scale	Participants will be asked to rate how comfortable they found the device to wear during a telephone administered exit interview.	15 minutes
Secondary	Convenience of remote monitoring assessed by a 5-point rating scale	Participants will be asked how the remote monitoring device affected their daily routine during a telephone administered exit interview. Responses will be collected using a 5-point rating scale of convenience.	15 minutes
Secondary	The average time required to support patients through the remote monitoring process	The amount of time that the study team spends on-boarding patients (fitting the devices and explaining how they work) and supporting patients to use the devices will be recorded, to calculate the average time that staff will need to support each patient and estimate the resource requirement for implementing remote monitoring.	6 months